Management of RLS During Pregnancy


Authors

Year

Country

Sample size

IRLSSG criteria + Face to face interview

Prevalence (%)

Ekbom [1]

1945

Sweden

486
 
11.3

Jolivet [3]

1953

France

100
 
27

Ekbom [4]

1960

Sweden

202
 
12.4

Goodman et al. [5]

1988

England

500
 
19

Suzuki et al. [22]

2003

Japan

16528
 
19.9

Manconi et al. [6]

2004

Italy

606


26

Tunc et al. [9]

2007

Turkey

146


26

Harano et al. [7]

2008

Japan

19441
 
2.9

Sikandar et al. [19]

2009

Pakistan

271


30

Facco et al. [47]

2010

US

189
 
17.5

Alves et al. [23]

2010

Brazil

524


13.5

Neau et al. [84]

2010

France

1022
 
23.7

Neau et al. [85]

2010

France

186
 
32.3

Ismailogullari et al. [86]

2010

Turkey

983


10.5

Uglane et al. [8]

2011

Norway

251
 
34

Balendran et al. [20]

2011

Australia

211
 
22.5

Sarberg et al. [13]

2012

Sweden

500


32

Chen et al. [87]

2012

Taiwan

461


10.4

Ko et al. [88]

2012

Korea

689
 
19.4

Vahdat et al. [89]

2013

Iran

443


17.8

Ramirez et al. [33]

2013

Peru

218


18.4

Minar et al. [90]

2013

Slovak

300
 
31.3

Hubner et al. [10]

2013

Switzerland

501


12

Wesstrom et al. [37]

2014

Sweden

1428
 
18.5

Shang et al. [91]

2014

China

1585


11.2

Terzi et al. [45]

2015

Turkey

600


13.8

Mindell et al. [92]

2015

US

2427
 
24

Ma et al. [35]

2015

China

3781


11.9


IRLSSSG International Restless Legs Study Group





Course and Prognosis


Among women with pregnancy-related RLS, around one third are already affected by RLS before pregnancy or already experienced the symptoms some time in their life [6]. Around 70–80% of these women report a worsening of RLS symptoms during pregnancy [6]. Considering the new onset cases, the incidence of RLS increases across pregnancy, with the highest rate reached in the third trimester, with an abrupt resolution of the symptoms occurring around the delivery, with very few cases continuing to be affected even in the puerperium [6, 10]. While the short-term prognosis of RLS is benign, the long-term one seems to be less favorable. After a follow up of approximately 7 years, Cesnik et al. [12] demonstrated that women who suffered of RLS during pregnancy have a 4 fold higher risk to develop an “idiopathic” RLS form compared to women who did not experience a pregnancy-related RLS. Besides, more than 60% of women who experienced RLS during pregnancy suffered of a relapse of RLS during a second pregnancy, while this percentage resulted of only around 3% for women who did not refer symptoms in a previous pregnancy [12]. Later on, Sarberg et al. [13], although after a shorter follow up of 3 years, substantially confirmed these results. The results obtained by these two long-term prospective studies evidently suggest a genetic predisposition behind the pregnancy RLS form [14].


Pathogenetic Hypotheses


The mechanism behind the pregnancy-related form is unknown. Few pathogenetic hypotheses have been postulated and concern the possible role of sexual hormones and iron deficiency during pregnancy [15, 16]. Particularly during the third trimester of pregnancy, when RLS symptoms are worst, estradiol, prolactin, and progesterone reach the highest blood level, and ferritin decreases at its minimum level [11]. Although with a pulsatile trend, prolactin keeps to stay at high levels also during puerperium, while estrogens and progesterone fall down quite dramatically around delivery, together with RLS symptoms [17]. Iron storage restore much gradually after delivery following a trend less comparable with RLS symptoms [18]. No solid experimental data are available in sustaining any role of the above-mentioned factors. The general idea consists in a genetic predisposition to the disease, while pregnancy may act as a precipitating factor for the symptoms appearance [11]. The genetic theory is supported by three findings: first, almost all pregnant women with a preexisting form of RLS get worst during pregnancy [6]; second, women with new pregnancy-related RLS have a high chance to develop an idiopathic not pregnancy-related RLS in the future [12, 13]; lastly, the chances to have a close familiar member affected by RLS is much higher in pregnant women with RLS than in pregnant women not affected [6, 19, 20]. The genetic hypothesis could be tested, and a study on the frequency of the already known allelic variants associated with idiopathic RLS is warrant [14, 21].

Other factors found to be associated with RLS during pregnancy are: leg cramps [6, 9], snoring [6] and daytime somnolence [6, 9, 22]. More uncertain is the role of age, smoking, body max index, and iron deficiency; herein, some studies found a significant differences in the above-listed parameters between pregnant with and without RLS [6, 19, 20, 22, 23]. Interesting is the influence of previous pregnancies on the chance to develop a pregnancy-related RLS form. Women who experienced RLS during a previous pregnancy have a higher risk for relapse in a following pregnancy [12]. The role of multiparity per sè is less clear. In more than few studies, the number of previous pregnancies was not a significant risk factor for RLS during the investigated pregnancy. However, a large epidemiological investigation found that multiparity per sè is a risk factor for the idiopathic, not pregnancy related, RLS form [24].


Consequences


It is well known that idiopathic RLS has a significant impact on quality of life [25]. The impact of RLS is mainly mediated by the evening/night restlessness which limits all activities that require rest and reduces duration and quality of sleep. In a long-term prospective, RLS has a clear impact also on mood [26] and cognitive functions [27], while its role as a cardiovascular risk is likely but still under investigation [2830]. Of course, the impact of RLS depends on the severity of symptoms, including its frequency and duration. Only few studies assessed the severity of RLS during pregnancy, finding unexpected results showing that in around 50% of women the standard RLS severity scale scored their symptoms as severe or very severe [10]. Prevalence of insomnia among pregnant women with RLS is higher than in women free of RLS [6]. In turn, a pour sleep quality during pregnancy is associated with a lower level of quality of life and possible consequences on pregnancy outcome. Preterm birth is more prevalent in women with pour quality of sleep during pregnancy compared to women without sleep complaint [31, 32]. Ramirez et al. [33] firstly found a significant association between RLS during pregnancy and pre-eclampsia. The other relevant pregnancy-related complications such as gestation diabetes, gestational hypertension, and eclampsia need still to be investigated in their relationship with RLS [3436].

Recent data suggest that RLS during pregnancy significantly increases the risk of perinatal depression, which are common and important complications affecting around 10–15% of pregnant women in different level of severity [37]. When untreated, perinatal depression increases the risk of preterm delivery, smoking and substance use, shortening of breast feed, abusive behavior toward children, and can have significant negative effects on partner’s relationship and emotional and cognitive development of infants [38].


Management of RLS During Pregnancy


The problem of RLS management during pregnancy has been underestimated for a long time, this was due to three important aspects: the pour knowledge of the syndrome, especially among gynecologists, which led to under diagnose the disease; the frequent transiency of symptoms which usually disappear around delivery, that led to consider RLS as a “normal” pregnancy-related phenomenon not well distinguishable from others such as ankle edema, fatigue, or insomnia, and therefore to be endured with patience by women until the end of pregnancy; the false belief of the low severity of symptoms. Indeed, symptoms can be severe with significant impact on women and potentially on the outcome of pregnancy, and, more importantly, even when RLS is mild and does not need to be treated, it should be recognize and well explained to women, who often are simply worried about their symptoms. Concerning this latter issue, the first and crucial step for a physician is to perform an accurate diagnosis of RLS. The recommendation is to use always the standard diagnostic criteria currently valid for idiopathic RLS [39]. There are no reasons to consider these criteria inadequate for pregnancy-related RLS. In both, idiopathic and pregnancy-related forms, the anatomical distribution and the other main features of symptoms are similar and a possible genetic vulnerability for RLS is suggested also for the pregnancy-related form, which is often associated with a positive family history and represents a risk for the onset of an idiopathic RLS in the future [12, 40]. The last version of the diagnostic criteria included a new fifth criterion specifically established to limit the misdiagnosis of the disease, reminding to always rule out possible mimics [41]. This is particularly necessary during pregnancy, in order to discriminate between true RLS and other frequent complications such as positional discomfort, leg cramps, venous stasis, ankle edema, and compression neuropathies [42]. However, should be taken into account that all the above-mentioned conditions may also co-occur with a real RLS.

The second step, after the recognition of RLS, is to quantify the severity of symptoms and their impact on the quality of life of women. Using the current definition of RLS, symptoms should be considered as clinically relevant when “significant distress or impairment in social, occupational, educational, or other important areas of functioning by its impact on sleep, mood, cognition, health, daily activities, behavior, or energy/vitality” [41]. Also during pregnancy, the severity of symptoms can be measured using the standard RLS rating scale validated by the international RLS study group [43]. This instrument consists in a 10 questions, self-administered questionnaire, which produces a final score ranging from 0 to 40, where a score between 10 and 20 corresponds to “moderate,” from 20 to 30 to “severe” and over 30 to “very severe.” The frequency of occurrence of symptoms is another relevant feature to be considered in the management of RLS during pregnancy; a suggested threshold for a clinical significance is twice per week.


Non-pharmacological Management During Pregnancy


After an accurate diagnosis and an appropriate quantification of symptoms, before considering a potential unsafe pharmacological approach, few possible non-pharmacological strategies should be contemplated [44]. In infrequent and mild cases, a simple reassurance by the physician on the nature and prognosis of symptoms can be sufficient.

The presence of factors already known to induce or aggravate RLS should be carefully checked and when is possible removed. Among these, a particular attention should be given to the comorbidity with other sleep disorders, especially sleep apnea, and primary insomnia [4547]. Alcohol and tobacco, even if not directly linked to RLS, should be limited or better avoided for their impact on sleep quality. A careful pharmacological history must be collected, this to identify possible drugs known to induce or exacerbate RLS [48]. Among these, antidepressants, neuroleptics, antiemetics, and sedative antihistamines are the most important to be recognized [49, 50].

Moderate and safe physical exercise, preferably not too close to the bedtime, should be encouraged based on their beneficial effects on idiopathic RLS [51, 52]. Non-traumatic activity, such as yoga, water aerobics, or walking, is warrant prior consent of the gynecologist [44]. Massages of legs might be beneficial in primary RLS and are potential helpful during pregnancy.

Despite their discrete safety during pregnancy, no adequate evidence for the efficacy of vitamins (folate, C, D, E) or magnesium are available for non-pregnant RLS. Folate is commonly supplemented in pregnant women, overall for their protective property on neuronal tube defects. Except in one single small study, no solid evidences support the effectiveness of folate in RLS [16, 53].


Iron Supplementation


A special consideration has to be dedicated to iron deficiency. A pathogenetic linkage between iron and idiopathic RLS is supported by several studies [5456] and pregnancy per se is the second cause of iron deficiency after abundant menstruation, especially in late pregnancy, when RLS symptoms are more prevalent or more severe. This is due to the expansion of the maternal red cells and the growth of fetus and placenta. Regardless to RLS, an oral iron supplementation is suggested for all pregnancies when ferritin value is lower than 30 mcg/L [57]. A threshold value of ferritin for pregnant women with RLS is not established. However, clinical guideline for management of RLS during pregnancy advise to supplement by a single of double daily dose of 65 mg of oral ferrous sulfate when ferritin levels drop below 75 mcg/L [44]. Despite oral iron adsorption is facilitate by concomitant intake of vitamin C, the safety of vitamin C during pregnancy is still debated [58]. An overload of iron is dangerous for women and their toddlers, and ferritin values should be rechecked regularly after starting with iron supplementation.

Consensus guideline suggested to consider intravenous (I.V.) iron administration when ferritin values are lower than 30 mcg/L or when oral iron administration was ineffective in correcting ferritin levels because of a pour intestinal adsorption [44]. Different types of I.V. iron are available on the market (dextran, sucrose, gluconate, and carboxy-maltose). The therapeutic dosage ranges between 500 and 1000 mg in single or multiple boluses. Physicians should be aware that recent febrile states or chronic inflammation might increase ferritin levels, and that in these cases a better indicator of iron storage is the iron percentage saturation. If women receive I.V. iron for the first time, than a particular attention has to be given to rare but severe anaphylactic reactions, and the administration needs to be performed at facilities where expert staff can promptly manage this complication. Except of this latter rare eventuality, iron supplementation during pregnancy is generally considered fairly safe. On the other hand, although some positive results mainly concerning I.V. iron, the effectiveness of iron in non-pregnant RLS need to be further consolidated. Few open label studies have been performed on the efficacy of I.V. iron in RLS during pregnancy, reporting encouraging results and no serious adverse events [59]. Large randomized controlled studies with I.V. and oral iron, in both idiopathic and pregnancy-related forms are needed.


Pharmacological Management During Pregnancy and Lactation


No structured investigations have been conducted so far on the pharmacological treatment of RLS during pregnancy. The information collected in the present paragraph come from the literature on idiopathic RLS to whom it concerns the efficacy, while from the literature of other diseases such as epilepsy, Parkinson disease or psychiatric conditions to whom it concerns the issue of safety. Based on the absence of specific literature, but motivated by an urgency to treat severe cases of RLS during pregnancy, the International Study Group endorsed a task force composed by nine experts in the field in order to suggest clinical practice guideline on the RLS management during pregnancy and lactation [44]. This paragraph is mostly based on the published results of this consensus. Figure 18.1 shows the final algorithm elaborated by the consensus which might help in RLS treatment during pregnancy and lactation.

A272893_1_En_18_Fig1_HTML.gif


Fig. 18.1
Algorithm for the diagnosis and management of RLS/WED during pregnancy and lactation. Dotted arrows: proceed only after assessment of severity, risks, and benefits by provider and patient. *After 1st trimester. Avoid concurrent use with diphenhydramine or anticonvulsants. §Refractory: an inadequate response to at least one nonpharmacologic intervention and iron (if ferritin <75 mcg/L), tried over an adequate period of time. Very severe, very refractory: a score of >30 on the International RLS Study Group rating scale and failure to respond to at least one nonpharmacologic treatment, iron (if ferritin <75 mcg/L), and one non-opioid pharmacologic treatment. Abbreviations: ER, extended release; IV, intravenous; % saturation, percent iron saturation; RLS, restless legs syndrome; TIBC, total iron binding capacity; WED, Willis–Ekbom disease (From [44], with permission.)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 23, 2017 | Posted by in NEUROLOGY | Comments Off on Management of RLS During Pregnancy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access